Benedict Financial Advisors Inc. reduced its stake in shares of Clorox Company (The) (NYSE:CLX) by 0.6% during the second quarter, Holdings Channel reports. The institutional investor owned 14,802 shares of the company’s stock after selling 92 shares during the period. Benedict Financial Advisors Inc.’s holdings in Clorox Company (The) were worth $1,957,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently bought and sold shares of CLX. American Beacon Advisors Inc. bought a new position in Clorox Company (The) during the first quarter valued at about $104,000. Quadrant Capital Group LLC boosted its position in Clorox Company (The) by 23.0% in the first quarter. Quadrant Capital Group LLC now owns 846 shares of the company’s stock valued at $106,000 after buying an additional 158 shares in the last quarter. Parkside Financial Bank & Trust boosted its position in Clorox Company (The) by 3.8% in the second quarter. Parkside Financial Bank & Trust now owns 796 shares of the company’s stock valued at $107,000 after buying an additional 29 shares in the last quarter. Valley National Advisers Inc. boosted its position in Clorox Company (The) by 0.6% in the first quarter. Valley National Advisers Inc. now owns 860 shares of the company’s stock valued at $116,000 after buying an additional 5 shares in the last quarter. Finally, Blue Chip Partners Inc. boosted its position in Clorox Company (The) by 0.7% in the first quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock valued at $122,000 after buying an additional 6 shares in the last quarter. 70.29% of the stock is currently owned by institutional investors.

Clorox Company (CLX) opened at 134.31 on Friday. Clorox Company has a 12-month low of $111.24 and a 12-month high of $141.76. The stock has a market capitalization of $17.34 billion, a PE ratio of 25.18 and a beta of 0.40. The stock’s 50 day moving average is $133.58 and its 200 day moving average is $133.56.

Clorox Company (The) (NYSE:CLX) last announced its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 EPS for the quarter, beating analysts’ consensus estimates of $1.49 by $0.04. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The company had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.65 billion. During the same quarter last year, the firm posted $1.30 EPS. The company’s quarterly revenue was up 2.9% on a year-over-year basis. Analysts forecast that Clorox Company will post $5.67 EPS for the current year.

ILLEGAL ACTIVITY WARNING: This news story was originally posted by Daily Political and is the sole property of of Daily Political. If you are reading this news story on another publication, it was illegally stolen and republished in violation of international copyright & trademark legislation. The original version of this news story can be viewed at https://www.dailypolitical.com/2017/08/12/benedict-financial-advisors-inc-lowers-position-in-clorox-company-the-nyseclx.html.

Several research analysts have issued reports on the company. Jefferies Group LLC reaffirmed a “hold” rating and issued a $137.00 price target (up previously from $136.00) on shares of Clorox Company (The) in a report on Wednesday. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $115.00 price target on shares of Clorox Company (The) in a report on Wednesday, August 2nd. Zacks Investment Research cut Clorox Company (The) from a “buy” rating to a “hold” rating in a report on Monday, July 31st. BidaskClub cut Clorox Company (The) from a “sell” rating to a “strong sell” rating in a report on Monday, July 24th. Finally, Barclays PLC reaffirmed an “equal weight” rating and issued a $136.00 price target (down previously from $140.00) on shares of Clorox Company (The) in a report on Friday, August 4th. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the company’s stock. Clorox Company (The) currently has an average rating of “Hold” and a consensus price target of $129.05.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.